Skip to main content
Program
Login Required
Poster Gallery
Browse by Category
Browse by Poster Number
Browse by Title
Browse by Author
Poster Wall
Sponsors
Exhibits
Exhibit Hall
Exhibitor List
Restricted Access
Delegates
Speakers
Attendees
CE Information/Evaluation
CE Information
Faculty Disclosures
Evaluation/Claim CE
iwCLL Committees & Membership
FAQ
Toggle navigation
Login
Search
Home
Program
Login Required
Poster Gallery
Browse by Category
Browse by Poster Number
Browse by Title
Browse by Author
Poster Wall
Sponsors
Exhibits
Exhibit Hall
Exhibitor List
Restricted Access
Delegates
Speakers
Attendees
CE Information/Evaluation
CE Information
Faculty Disclosures
Evaluation/Claim CE
iwCLL Committees & Membership
FAQ
iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Tweet
Megan Othus, PhD
SWOG Statistical Center
NA
Poster(s):
3007 - Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab (VO) versus Delayed Therapy with VO in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study (SWOG S1925; NCT#04269902)
Back to Top
